Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The industry rank for IHH Healthcare Bhd's 9-Day RSI or its related term are showing as below:
XKLS:5225's 9-Day RSI is ranked worse than 54.66% of 697
companies
in the Healthcare Providers & Services industry
Industry Median: 50.24
vs XKLS:5225: 50.00
IHH Healthcare Bhd (XKLS:5225) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
IHH Healthcare Bhd 9-Day RSI Related Terms
XKLS:5225 vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, IHH Healthcare Bhd's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IHH Healthcare Bhd 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, IHH Healthcare Bhd's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where IHH Healthcare Bhd's 9-Day RSI falls into.
IHH Healthcare Bhd (XKLS:5225) 9-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IHH Healthcare Bhd (XKLS:5225) has a 9-Day RSI of 50.00 as of Jul. 14, 2026. According to the industry distribution chart, IHH Healthcare Bhd ranks #381 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 54.7%.
Is IHH Healthcare Bhd's 9-Day RSI too high?
IHH Healthcare Bhd's current 9-Day RSI is 50.00. The Healthcare Providers & Services industry median 9-Day RSI is 50.24. IHH Healthcare Bhd's value of 50.00 is 0.5% below this industry median. Based on the distribution chart, IHH Healthcare Bhd ranks #381 out of 697 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, IHH Healthcare Bhd has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IHH Healthcare Bhd's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, IHH Healthcare Bhd ranks #381 out of 697 companies for 9-Day RSI. This places IHH Healthcare Bhd in the lower half of its industry. The industry median 9-Day RSI is 50.24. IHH Healthcare Bhd's value of 50.00 is 0.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 50.24, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IHH Healthcare Bhd's current 9-Day RSI of 50.00 is 0.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 50.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IHH Healthcare Bhd's current 9-Day RSI is 50.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IHH Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, IHH Healthcare Bhd (XKLS:5225) is currently considered Fairly Valued. The stock's GF Value™ is RM8.12, compared to a current price of RM8.45 — trading 4.1% above its estimated fair value. The current 9-Day RSI is 50.00 and 0.5% below the Healthcare Providers & Services industry median of 50.24. IHH Healthcare Bhd's overall GF Score™ is 85/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For IHH Healthcare Bhd (XKLS:5225), the current 9-Day RSI is 50.00 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IHH Healthcare Bhd (XKLS:5225) Overvalued in 2026?
Based on GuruFocus' analysis, IHH Healthcare Bhd stock appears to be overvalued.
The current stock price of RM8.45 is trading 4.1% above its estimated GF Value™ of RM8.12.
GuruFocus considers IHH Healthcare Bhd to be Fairly Valued.
Key valuation signals for XKLS:5225:
9-Day RSI: 50.00
GF Value™: RM8.12 vs. price of RM8.45 (4.1% above fair value)
Industry Position: 0.5% below the Healthcare Providers & Services median (#381 of 697)
No single metric tells the full story. See the XKLS:5225 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IHH Healthcare Bhd is an investment holding company. Through its subsidiaries, it is a healthcare services provider that operates a network of hospitals. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The company's reportable segments include Healthcare services, Laboratories services, and Management fees. The majority of its revenue is generated from the Healthcare services segment, which relates to contracts with patients in which performance obligations are to provide healthcare services. Geographically, the company derives maximum revenue from Turkiye and Europe, followed by Singapore, Malaysia, India, Greater China, and Others.
85GF Score
Get the complete analysis for XKLS:5225
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:5225 has been successfully added to your 
